Predictors of Long‐Term Survival in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

Background Immune checkpoint inhibitor–associated myocarditis (ICIM) carries high rates of morbidity and death, but clinical outcomes vary widely. Little is known about the clinical variables associated with long‐term survival. Methods In this case–control study, patients diagnosed with ICIM at Mass...

Полное описание

Библиографические подробности

Главные авторы:	Nikhil Dubey, Chia‐Yun Wu, Leyre Zubiri, Magdalena Fay, Sherin J. Rouhani, Ross D. Merkin, Joie Sun, Joseph J. Locascio, Tomas G. Neilan, Kerry L. Reynolds, Daniel A. Zlotoff
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2025-07-01
Серии:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Предметы:	immune checkpoint inhibitor myocarditis immunosuppression survivorship
Online-ссылка:	https://www.ahajournals.org/doi/10.1161/JAHA.124.038719
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!